Prevention research presented at HIV Glasgow will also include a systematic review and meta-analysis of real-world data mapping HIV prevalence against PrEP uptake, health economic data ... Islatravir ...

Merck's consistent dividend payments over 34 years, healthy balance sheet, and attractive valuation highlight its investment ...

Operator Good day, and welcome to the OPKO Health third quarter of 2024 financial results conference call. All participants ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Multiple sclerosis (MS) is a chronic neurological disorder affecting the central nervous system (CNS), particularly the brain ...

Illumina Complete Long Read Prep, Human. Compatible with sequencing systems for high ... partnered with Molecular Health to ...

Leidos has announced a partnership with the University of Edinburgh in the United Kingdom to advance AI and data science solutions. The partnership will leverage the university's Bayes Centre, an ...

During an R&D update yesterday Merck said it is hoping to claim eight new cardiovascular therapy approvals between now and 2030, for diseases like atherosclerosis, heart failure, pulmonary ...

New Research Reveals How Large-Scale Adoption of Electric Vehicles Can Improve Air Quality and Human Health Oct. 15, 2024 — A new study suggests that large-scale adoption of electric vehicles ...

Welcome to the Moderna third quarter 2024 conference call. [Operator instructions] Please be advised today's conference is ...

Copyright © 2024 MarketWatch, Inc. All rights reserved.